ADIL vs PAYC · $6.0M cap vs P/E 33, rev $1.10B
Adial Pharmaceuticals Inc (ADIL) versus Paycom Soft (PAYC) — a side-by-side from cached financials, not a winner call.
Adial Pharmaceuticals Inc (ADIL) is a biotechnology company listed on NASDAQ.
Paycom Soft (PAYC) is a software - application company listed on US.
ADIL does not have a complete income-statement cache yet.
Latest reported PAYC revenue for 2026-06-30 was $1.10B. Net income was $263.1M. Revenue was up 92.9% from 2026-03-31 to 2026-06-30. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
ADIL currently screens at market cap $6.0M. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
Not investment advice. Open the ADIL and PAYC stock pages for the full models.
Not investment advice.